We are live on
!
Find out more
GP
GLG Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
21.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.92%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.43B
AUM Growth
-$936M
(-21%)
Cap. Flow
-$1.57B
Cap. Flow
% of AUM
-45.64%
Top 10 Holdings %
Top 10 Hldgs %
19.04%
Holding
546
New
124
Increased
63
Reduced
108
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$59.7M |
| 2 |
HCT
AMRICAN RLTY CAP HEALTHCARE TRUST INC. COMMON STOCK
HCT
|
+$51.2M |
| 3 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$50.2M |
| 4 |
Cardinal Health
CAH
|
+$40.5M |
| 5 |
AGN
Allergan Inc
AGN
|
+$34.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$71.2M |
| 2 |
McKesson
MCK
|
+$61.3M |
| 3 |
Methanex
MEOH
|
+$45.9M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$43.6M |
| 5 |
Revvity
RVTY
|
+$38.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.29% |
| 2 | Consumer Discretionary | 7.94% |
| 3 | Technology | 7.1% |
| 4 | Financials | 5.32% |
| 5 | Industrials | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
126
CALL
DELISTED
WW International
WW
| $4.8M | 0.14% |
+193,100
| New | +$5.19M |
|
|
OCR
127
DELISTED
OMNICARE INC
OCR
| $4.75M | 0.14% |
65,153
-52,825
| -45% | -$3.59M |
|
128
Regeneron Pharmaceuticals
REGN
$68.8B
| $4.7M | 0.14% |
11,463
-4,439
| -28% | -$1.75M |
|
|
CIMT
129
DELISTED
CIMATRON LTD ORD SHS
CIMT
| $4.34M | 0.13% |
+490,022
| New | +$3.4M |
|
130
CALL
Capri Holdings
CPRI
$1.77B
| $4.22M | 0.12% |
+56,200
| New | +$4.19M |
|
|
OSG
131
Octave Specialty Group
OSG
$252M
| $4.2M | 0.12% |
171,240
+23,075
| +16% | +$537K |
|
|
ICPT
132
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.15M | 0.12% |
+26,597
| New | +$4.91M |
|
133
Molson Coors Class B
TAP
$7.68B
| $4.02M | 0.12% |
+53,900
| New | +$4M |
|
134
Energy Transfer Partners
ET
$70.1B
| $3.97M | 0.12% |
138,278
-285,974
| -67% | -$8.24M |
|
135
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $3.94M | 0.11% |
19,177
+16,864
| +729% | +$3.39M |
|
|
ROIQ
136
DELISTED
ROI ACQUISITION CORP II COM STK
ROIQ
| $3.93M | 0.11% |
400,000
| – | – |
|
|
DISH
137
DELISTED
DISH Network Corp.
DISH
| $3.83M | 0.11% |
+52,562
| New | +$3.54M |
|
|
KATE
138
DELISTED
Kate Spade & Company
KATE
| $3.8M | 0.11% |
+118,830
| New | +$3.39M |
|
139
Alphabet (Google) Class C
GOOG
$3.9T
| $3.8M | 0.11% |
144,857
-993,941
| -87% | -$26.7M |
|
140
Dycom Industries
DY
$12.9B
| $3.79M | 0.11% |
108,009
+58,600
| +119% | +$1.75M |
|
141
Palo Alto Networks
PANW
$264B
| $3.79M | 0.11% |
185,430
| – | – |
|
142
CALL
Newmont
NEM
$99.5B
| $3.78M | 0.11% |
200,000
| – | – |
|
143
Sempra
SRE
$60.8B
| $3.78M | 0.11% |
67,200
-665,932
| -91% | -$36.3M |
|
144
TE Connectivity
TEL
$58.8B
| $3.69M | 0.11% |
58,380
-9,387
| -14% | -$565K |
|
|
SLXP
145
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $3.63M | 0.11% |
31,572
-18,428
| -37% | -$2.23M |
|
|
MTCN
146
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $3.53M | 0.1% |
200,000
| – | – |
|
147
Ring Energy
REI
$322M
| $3.5M | 0.1% |
333,334
| – | – |
|
148
Biogen
BIIB
$29.9B
| $3.34M | 0.1% |
9,835
+5,396
| +122% | +$1.75M |
|
|
VMW
149
DELISTED
VMware, Inc
VMW
| $3.34M | 0.1% |
40,430
+20,627
| +104% | +$1.76M |
|
|
GFIG
150
DELISTED
GFI GROUP INC
GFIG
| $3.31M | 0.1% |
607,545
+407,545
| +204% | +$2.14M |
|
Similar funds
IH
GL
TAM
SI
GES
AS
QAM
BTIS
GLG Partners's Q4 2014 Portfolio in Review
As of Q4 2014, GLG Partners held 546 positions worth $3.43B, down 21% from $4.37B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
GLG Partners withdrew a net $1.57B in Q4 2014, closing 158 positions and reducing 108 holdings. Its most notable exit was Methanex, an estimated $45.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, GLG Partners opened a new position in CUBIST PHARMACEUTICALS INC worth $77.3M.
- GLG Partners's largest Q4 2014 buy was CUBIST PHARMACEUTICALS INC: 767,613 shares worth $77.3M.
- GLG Partners added most to TRW AUTOMOTIVE HOLDINGS CORP in Q4 2014, an estimated $50.2M increase.
- GLG Partners's biggest Q4 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $71.2M.
- GLG Partners fully exited Methanex in Q4 2014, selling an estimated $45.9M.
- GLG Partners's ten largest holdings make up 19% of its $3.43B portfolio in Q4 2014.
- GLG Partners opened 124 new positions and closed 158 in Q4 2014.
- GLG Partners's portfolio value fell 21% quarter-over-quarter to $3.43B.
Based on GLG Partners's 13F filing for Q4 2014, filed 17 Feb 2015.